Atlas Logo
Chinese national free antiretroviral treatment cohort
BACK
Sample details

This study aims to evaluate the effectiveness and outcomes of antiretroviral therapy (ART) by examining health and treatment responses in HIV-positive individuals. The study began in 2002 with a pilot programme in one county in Henan Province, involving approximately 7,000 participants. By the end of 2003, the programme had expanded to include nine provinces and became a nationwide cohort by 2004. In 2007, the study included over 42,000 participants, comprising both adult and paediatric cohorts. After treatment initiation, follow-up visits are scheduled at 0.5, 1, 2, and 3 months, and once every 3 months thereafter.

Study design
Cohort - open

Number of participants at first data collection

42,126 (adult participants)

799 (paediatric participants)

Recruitment is ongoing

Age at first data collection

≥ 15 years (adult participants)

< 15 years (paediatric participants)

Participant year of birth

Varied (adult participants)

Varied (paediatric participants)

Participant sex
All

Representative sample at baseline?
The HIV/AIDS treatment across all of China.

Sample features

People living with HIV
Dataset details

Country

China

Year of first data collection

2002

Primary Institutions

Chinese Center for Disease Control and Prevention (中国疾病预防控制中心, CCDC)

National Center for AIDS/STD Control and Prevention (中国疾病预防控制中心性病艾滋病预防控制中心, NCAIDS)

Links

doi.org/10.3760/cma.j.issn.0366-6999.2012.19.028

Profile paper DOI

doi.org/10.1093/ije/dyp233

Funders

Ministry of Health

National Institutes of Health (NIH)

Ongoing?
Yes

Data types collected

Quantitative data collection
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Self-report questionnaire – paper or computer assisted
Qualitative data collection
  • None
Neuroimaging data collection
  • None
Linked or secondary data
  • None
Features

Engagement

  • None
  • Keywords

    Acquired immunodeficiency syndrome (AIDS)
    Antiretroviral therapy (ART)
    Disease management
    Human immunodeficiency virus (HIV)
    Population health
    Sexually transmitted infections (STIs)
    Treatment experiences and outcomes
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis